Austar Lifesciences (HKSE:06118) Net Issuance of Debt : HK$-83 Mil (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Austar Lifesciences Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Austar Lifesciences's net issuance of debt for the six months ended in Dec. 2024 was HK$-35 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-83 Mil.

Austar Lifesciences Net Issuance of Debt Historical Data

The historical data trend for Austar Lifesciences's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Net Issuance of Debt Chart

Austar Lifesciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Debt

Get a 7-Day Free Trial

11.67

96.86

165.90

197.76

-82.11

Austar Lifesciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Issuance of Debt	Get a 7-Day Free Trial															152.45	115.11	82.65	-47.81	-34.69

Austar Lifesciences Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-83 Mil.

Austar Lifesciences Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (HKSE:06118) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1018 Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipments and consumables in the People's Republic of China. The company's segments include Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC). Geographically, it derives the majority of its revenue from Mainland China.

Executives

True Worth Global Limited	2101 Beneficial owner
Cheung Chau Ping	2202 Interest of your spouse
Ho Kin Hung	2201 Interest of corporation controlled by you

Austar Lifesciences Headlines

No Headlines